Email updates

Keep up to date with the latest news and content from BMC Women's Health and BioMed Central.

Open Access Highly Accessed Research article

Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat

Noel N Kim1*, Miljan Stankovic1, Abdullah Armagan2, Tulay T Cushman3, Irwin Goldstein1 and Abdulmaged M Traish14

Author Affiliations

1 Institute for Sexual Medicine, Department of Urology, Boston University School of Medicine, Boston, Massachusetts, USA

2 Department of Urology, Suleyman Demirel University Faculty of Medicine, Isparta, Turkey

3 Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA

4 Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA

For all author emails, please log on.

BMC Women's Health 2006, 6:14  doi:10.1186/1472-6874-6-14

Published: 13 September 2006

Abstract

Background

Tamoxifen, a selective estrogen receptor modulator with both estrogenic and anti-estrogenic activity, is widely used as adjuvant therapy in breast cancer patients. Treatment with tamoxifen is associated with sexual side effects, such as increased vaginal dryness and pain/discomfort during sexual activity. There have been limited investigations of the effect of tamoxifen on estrogen-dependent peripheral genital arousal responses. The objective of this study was to investigate the effects of tamoxifen on vaginal physiology in the rat.

Methods

Female Sprague-Dawley rats were subjected to sham surgery or bilateral ovariectomy. After 2 weeks, sham-operated rats were implanted with subcutaneous osmotic infusion pumps containing vehicle (control) or tamoxifen (150 μg/day). Ovariectomized rats were similarly infused with vehicle. After an additional 2 weeks, vaginal blood flow responses to pelvic nerve stimulation were measured by laser Doppler flowmetry and vaginal tissue was collected for histological and biochemical assay.

Results

Tamoxifen treatment did not change plasma estradiol concentrations relative to control animals, while ovariectomized rats exhibited a 60% decrease in plasma estradiol. Tamoxifen treatment caused a significant decrease in mean uterine weight, but did not alter mean vaginal weight. Vaginal blood flow was significantly decreased in tamoxifen-infused rats compared to controls. Similar to ovariectomized animals, estrogen receptor binding was increased and arginase enzyme activity was decreased in tamoxifen-infused rats. However, different from control and ovariectomized animals, the vaginal epithelium in tamoxifen-infused rats appeared highly mucified. Periodic acid-Schiff staining confirmed a greater production of carbohydrate-rich compounds (e.g. mucin, glycogen) by the vaginal epithelium of tamoxifen-infused rats.

Conclusion

The observations suggest that tamoxifen exerts both anti-estrogenic and pro-estrogenic effects in the vagina. These physiological alterations may eventually lead to vaginal atrophy and compromise sexual function.